カテゴリー： QYResearch, 世界

世界の細胞性腫瘍抗原p53市場

QYResearchが発行した調査報告書（DATA909X05261）
◆英語タイトル：Global Cellular Tumor Antigen p53 Market Professional Survey Report 2019
◆商品コード：DATA909X05261
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月15日（※2024年版があります。お問い合わせください）
◆ページ数：111
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
※本調査レポートは、細胞性腫瘍抗原p53の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、COTI-2、D-12PGJ3、APR-246、ATRN-502、セネルセンナトリウム、MJ-05、MX-225、その他に、用途別には、卵巣がん、前立腺がん、脳がん、その他にセグメント区分し、細胞性腫瘍抗原p53の世界市場を分析しました。


・エグゼクティブ・サマリー
・細胞性腫瘍抗原p53の世界市場概要
・細胞性腫瘍抗原p53の製造コスト構成分析
・細胞性腫瘍抗原p53の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・細胞性腫瘍抗原p53の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・細胞性腫瘍抗原p53のセグメント分析（種類別）
（COTI-2、D-12PGJ3、APR-246、ATRN-502、セネルセンナトリウム、MJ-05、MX-225、その他）
・細胞性腫瘍抗原p53のセグメント分析（用途別）
（卵巣がん、前立腺がん、脳がん、その他）
・細胞性腫瘍抗原p53の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Advaxis, Inc.、American Gene Technologies International Inc.、Aprea AB、Cellceutix Corporation、Critical Outcome Technologies Inc.、Eleos Inc.、ORCA Therapeutics B.V.、OSE Pharma SA、PCI Biotech Holding ASA、Quark Pharmaceuticals, Inc.、Stemline Therapeutics, Inc.、Shenzen SiBiono GeneTech Co., Ltd.、SK Biopharmaceuticals Co., Ltd.、Tara Immuno-Oncology Therapeutics LLC、Z53 Therapeutics, LLC、）
・細胞性腫瘍抗原p53の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Cellular Tumor Antigen p53 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Cellular Tumor Antigen p53 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cellular Tumor Antigen p53 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cellular Tumor Antigen p53 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cellular Tumor Antigen p53 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Advaxis, Inc.
American Gene Technologies International Inc.
Aprea AB
Cellceutix Corporation
Critical Outcome Technologies Inc.
Eleos Inc.
ORCA Therapeutics B.V.
OSE Pharma SA
PCI Biotech Holding ASA
Quark Pharmaceuticals, Inc.
Stemline Therapeutics, Inc.
Shenzen SiBiono GeneTech Co., Ltd.
SK Biopharmaceuticals Co., Ltd.
Tara Immuno-Oncology Therapeutics LLC
Z53 Therapeutics, LLC

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
COTI-2
D-12PGJ3
APR-246
ATRN-502
Cenersen Sodium
MJ-05
MX-225
Others

Segment by Application
Ovarian Cancer
Prostate Cancer
Brain Cancer
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Cellular Tumor Antigen p53
1.1 Definition of Cellular Tumor Antigen p53
1.2 Cellular Tumor Antigen p53 Segment by Type
1.2.1 Global Cellular Tumor Antigen p53 Production Growth Rate Comparison by Types (2014-2025)
1.2.2 COTI-2
1.2.3 D-12PGJ3
1.2.4 APR-246
1.2.5 ATRN-502
1.2.6 Cenersen Sodium
1.2.7 MJ-05
1.2.8 MX-225
1.2.9 Others
1.3 Cellular Tumor Antigen p53 Segment by Applications
1.3.1 Global Cellular Tumor Antigen p53 Consumption Comparison by Applications (2014-2025)
1.3.2 Ovarian Cancer
1.3.3 Prostate Cancer
1.3.4 Brain Cancer
1.3.5 Others
1.4 Global Cellular Tumor Antigen p53 Overall Market
1.4.1 Global Cellular Tumor Antigen p53 Revenue (2014-2025)
1.4.2 Global Cellular Tumor Antigen p53 Production (2014-2025)
1.4.3 North America Cellular Tumor Antigen p53 Status and Prospect (2014-2025)
1.4.4 Europe Cellular Tumor Antigen p53 Status and Prospect (2014-2025)
1.4.5 China Cellular Tumor Antigen p53 Status and Prospect (2014-2025)
1.4.6 Japan Cellular Tumor Antigen p53 Status and Prospect (2014-2025)
1.4.7 Southeast Asia Cellular Tumor Antigen p53 Status and Prospect (2014-2025)
1.4.8 India Cellular Tumor Antigen p53 Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Cellular Tumor Antigen p53
2.3 Manufacturing Process Analysis of Cellular Tumor Antigen p53
2.4 Industry Chain Structure of Cellular Tumor Antigen p53

3 Development and Manufacturing Plants Analysis of Cellular Tumor Antigen p53
3.1 Capacity and Commercial Production Date
3.2 Global Cellular Tumor Antigen p53 Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Cellular Tumor Antigen p53
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Cellular Tumor Antigen p53 Production and Capacity Analysis
4.2 Cellular Tumor Antigen p53 Revenue Analysis
4.3 Cellular Tumor Antigen p53 Price Analysis
4.4 Market Concentration Degree

5 Cellular Tumor Antigen p53 Regional Market Analysis
5.1 Cellular Tumor Antigen p53 Production by Regions
5.1.1 Global Cellular Tumor Antigen p53 Production by Regions
5.1.2 Global Cellular Tumor Antigen p53 Revenue by Regions
5.2 Cellular Tumor Antigen p53 Consumption by Regions
5.3 North America Cellular Tumor Antigen p53 Market Analysis
5.3.1 North America Cellular Tumor Antigen p53 Production
5.3.2 North America Cellular Tumor Antigen p53 Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Cellular Tumor Antigen p53 Import and Export
5.4 Europe Cellular Tumor Antigen p53 Market Analysis
5.4.1 Europe Cellular Tumor Antigen p53 Production
5.4.2 Europe Cellular Tumor Antigen p53 Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Cellular Tumor Antigen p53 Import and Export
5.5 China Cellular Tumor Antigen p53 Market Analysis
5.5.1 China Cellular Tumor Antigen p53 Production
5.5.2 China Cellular Tumor Antigen p53 Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Cellular Tumor Antigen p53 Import and Export
5.6 Japan Cellular Tumor Antigen p53 Market Analysis
5.6.1 Japan Cellular Tumor Antigen p53 Production
5.6.2 Japan Cellular Tumor Antigen p53 Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Cellular Tumor Antigen p53 Import and Export
5.7 Southeast Asia Cellular Tumor Antigen p53 Market Analysis
5.7.1 Southeast Asia Cellular Tumor Antigen p53 Production
5.7.2 Southeast Asia Cellular Tumor Antigen p53 Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Cellular Tumor Antigen p53 Import and Export
5.8 India Cellular Tumor Antigen p53 Market Analysis
5.8.1 India Cellular Tumor Antigen p53 Production
5.8.2 India Cellular Tumor Antigen p53 Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Cellular Tumor Antigen p53 Import and Export

6 Cellular Tumor Antigen p53 Segment Market Analysis (by Type)
6.1 Global Cellular Tumor Antigen p53 Production by Type
6.2 Global Cellular Tumor Antigen p53 Revenue by Type
6.3 Cellular Tumor Antigen p53 Price by Type

7 Cellular Tumor Antigen p53 Segment Market Analysis (by Application)
7.1 Global Cellular Tumor Antigen p53 Consumption by Application
7.2 Global Cellular Tumor Antigen p53 Consumption Market Share by Application (2014-2019)

8 Cellular Tumor Antigen p53 Major Manufacturers Analysis
8.1 Advaxis, Inc.
8.1.1 Advaxis, Inc. Cellular Tumor Antigen p53 Production Sites and Area Served
8.1.2 Advaxis, Inc. Product Introduction, Application and Specification
8.1.3 Advaxis, Inc. Cellular Tumor Antigen p53 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 American Gene Technologies International Inc.
8.2.1 American Gene Technologies International Inc. Cellular Tumor Antigen p53 Production Sites and Area Served
8.2.2 American Gene Technologies International Inc. Product Introduction, Application and Specification
8.2.3 American Gene Technologies International Inc. Cellular Tumor Antigen p53 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Aprea AB
8.3.1 Aprea AB Cellular Tumor Antigen p53 Production Sites and Area Served
8.3.2 Aprea AB Product Introduction, Application and Specification
8.3.3 Aprea AB Cellular Tumor Antigen p53 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Cellceutix Corporation
8.4.1 Cellceutix Corporation Cellular Tumor Antigen p53 Production Sites and Area Served
8.4.2 Cellceutix Corporation Product Introduction, Application and Specification
8.4.3 Cellceutix Corporation Cellular Tumor Antigen p53 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Critical Outcome Technologies Inc.
8.5.1 Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Production Sites and Area Served
8.5.2 Critical Outcome Technologies Inc. Product Introduction, Application and Specification
8.5.3 Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Eleos Inc.
8.6.1 Eleos Inc. Cellular Tumor Antigen p53 Production Sites and Area Served
8.6.2 Eleos Inc. Product Introduction, Application and Specification
8.6.3 Eleos Inc. Cellular Tumor Antigen p53 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 ORCA Therapeutics B.V.
8.7.1 ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Production Sites and Area Served
8.7.2 ORCA Therapeutics B.V. Product Introduction, Application and Specification
8.7.3 ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 OSE Pharma SA
8.8.1 OSE Pharma SA Cellular Tumor Antigen p53 Production Sites and Area Served
8.8.2 OSE Pharma SA Product Introduction, Application and Specification
8.8.3 OSE Pharma SA Cellular Tumor Antigen p53 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 PCI Biotech Holding ASA
8.9.1 PCI Biotech Holding ASA Cellular Tumor Antigen p53 Production Sites and Area Served
8.9.2 PCI Biotech Holding ASA Product Introduction, Application and Specification
8.9.3 PCI Biotech Holding ASA Cellular Tumor Antigen p53 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Quark Pharmaceuticals, Inc.
8.10.1 Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Production Sites and Area Served
8.10.2 Quark Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.10.3 Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Stemline Therapeutics, Inc.
8.12 Shenzen SiBiono GeneTech Co., Ltd.
8.13 SK Biopharmaceuticals Co., Ltd.
8.14 Tara Immuno-Oncology Therapeutics LLC
8.15 Z53 Therapeutics, LLC

9 Development Trend of Analysis of Cellular Tumor Antigen p53 Market
9.1 Global Cellular Tumor Antigen p53 Market Trend Analysis
9.1.1 Global Cellular Tumor Antigen p53 Market Size (Volume and Value) Forecast 2019-2025
9.2 Cellular Tumor Antigen p53 Regional Market Trend
9.2.1 North America Cellular Tumor Antigen p53 Forecast 2019-2025
9.2.2 Europe Cellular Tumor Antigen p53 Forecast 2019-2025
9.2.3 China Cellular Tumor Antigen p53 Forecast 2019-2025
9.2.4 Japan Cellular Tumor Antigen p53 Forecast 2019-2025
9.2.5 Southeast Asia Cellular Tumor Antigen p53 Forecast 2019-2025
9.2.6 India Cellular Tumor Antigen p53 Forecast 2019-2025
9.3 Cellular Tumor Antigen p53 Market Trend (Product Type)
9.4 Cellular Tumor Antigen p53 Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Cellular Tumor Antigen p53 Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Cellular Tumor Antigen p53
Table Global Cellular Tumor Antigen p53 Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Cellular Tumor Antigen p53 Production Market Share by Types in 2018
Figure COTI-2 Product Picture
Figure D-12PGJ3 Product Picture
Figure APR-246 Product Picture
Figure ATRN-502 Product Picture
Figure Cenersen Sodium Product Picture
Figure MJ-05 Product Picture
Figure MX-225 Product Picture
Figure Others Product Picture
Table Global Cellular Tumor Antigen p53 Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Cellular Tumor Antigen p53 Consumption Market Share by Applications in 2018
Figure Ovarian Cancer
Figure Prostate Cancer
Figure Brain Cancer
Figure Others
Figure Global Cellular Tumor Antigen p53 Revenue (Million USD) (2014-2025)
Figure Global Cellular Tumor Antigen p53 Production (K Pcs) (2014-2025)
Figure North America Cellular Tumor Antigen p53 Market Size (Million USD) (2014-2025)
Figure Europe Cellular Tumor Antigen p53 Market Size (Million USD) (2014-2025)
Figure China Cellular Tumor Antigen p53 Market Size (Million USD) (2014-2025)
Figure Japan Cellular Tumor Antigen p53 Market Size (Million USD) (2014-2025)
Figure Southeast Asia Cellular Tumor Antigen p53 Market Size (Million USD) (2014-2025)
Figure India Cellular Tumor Antigen p53 Market Size (Million USD) (2014-2025)
Table Cellular Tumor Antigen p53 Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Cellular Tumor Antigen p53 in 2018
Figure Manufacturing Process Analysis of Cellular Tumor Antigen p53
Figure Industry Chain Structure of Cellular Tumor Antigen p53
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Cellular Tumor Antigen p53 Manufacturing Plants Distribution
Table Cellular Tumor Antigen p53 Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Cellular Tumor Antigen p53 Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Cellular Tumor Antigen p53 Production (K Pcs) of Major Manufacturers (2014-2019)
Table Cellular Tumor Antigen p53 Production Market Share of Major Manufacturers (2014-2019)
Figure Cellular Tumor Antigen p53 Production Share by Manufacturers in 2018
Table Cellular Tumor Antigen p53 Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Cellular Tumor Antigen p53 Revenue Market Share of Major Manufacturers (2014-2019)
Figure Cellular Tumor Antigen p53 Revenue Share by Manufacturers in 2018
Table Cellular Tumor Antigen p53 Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Cellular Tumor Antigen p53 Production by Regions 2014-2019 (K Pcs)
Table Global Cellular Tumor Antigen p53 Production Market Share by Regions 2014-2019
Figure Global Cellular Tumor Antigen p53 Production Market Share by Regions in 2018
Table Global Cellular Tumor Antigen p53 Revenue by Regions 2014-2019 (Million USD)
Table Global Cellular Tumor Antigen p53 Revenue Market Share by Regions 2014-2019
Figure Global Cellular Tumor Antigen p53 Revenue Market Share by Regions in 2018
Table Global Cellular Tumor Antigen p53 Consumption by Regions 2014-2019 (K Pcs)
Table Global Cellular Tumor Antigen p53 Consumption Market Share by Regions 2014-2019
Figure North America Cellular Tumor Antigen p53 Production Growth Rate 2014-2019 (K Pcs)
Figure North America Cellular Tumor Antigen p53 Revenue Growth Rate 2014-2019 (Million USD)
Table North America Cellular Tumor Antigen p53 Production, Consumption Import and Export (K Pcs)
Figure Europe Cellular Tumor Antigen p53 Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Cellular Tumor Antigen p53 Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Cellular Tumor Antigen p53 Production, Consumption Import and Export (K Pcs)
Figure China Cellular Tumor Antigen p53 Production Growth Rate 2014-2019 (K Pcs)
Figure China Cellular Tumor Antigen p53 Revenue Growth Rate 2014-2019 (Million USD)
Table China Cellular Tumor Antigen p53 Production, Consumption Import and Export (K Pcs)
Figure Japan Cellular Tumor Antigen p53 Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Cellular Tumor Antigen p53 Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Cellular Tumor Antigen p53 Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Cellular Tumor Antigen p53 Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Cellular Tumor Antigen p53 Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Cellular Tumor Antigen p53 Production, Consumption Import and Export (K Pcs)
Figure India Cellular Tumor Antigen p53 Production Growth Rate 2014-2019 (K Pcs)
Figure India Cellular Tumor Antigen p53 Revenue Growth Rate 2014-2019 (Million USD)
Table India Cellular Tumor Antigen p53 Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Cellular Tumor Antigen p53 Market Share by Application (2014-2019)
Figure Global Value (Consumption) Cellular Tumor Antigen p53 Market Share by Application (2014-2019)
Table Advaxis, Inc. Cellular Tumor Antigen p53 Production Sites and Area Served
Table Advaxis, Inc. Cellular Tumor Antigen p53 Product Introduction, Application and Specification
Table Advaxis, Inc. Cellular Tumor Antigen p53 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Advaxis, Inc. Cellular Tumor Antigen p53 Production Growth Rate (2014-2019)
Table Advaxis, Inc. Cellular Tumor Antigen p53 Production Market Share (2014-2019)
Figure Advaxis, Inc. Cellular Tumor Antigen p53 Revenue Market Share (2014-2019)
Table Advaxis, Inc. Cellular Tumor Antigen p53 Main Business and Markets Served
Table American Gene Technologies International Inc. Cellular Tumor Antigen p53 Production Sites and Area Served
Table American Gene Technologies International Inc. Cellular Tumor Antigen p53 Product Introduction, Application and Specification
Table American Gene Technologies International Inc. Cellular Tumor Antigen p53 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table American Gene Technologies International Inc. Cellular Tumor Antigen p53 Production Growth Rate (2014-2019)
Table American Gene Technologies International Inc. Cellular Tumor Antigen p53 Production Market Share (2014-2019)
Figure American Gene Technologies International Inc. Cellular Tumor Antigen p53 Revenue Market Share (2014-2019)
Table American Gene Technologies International Inc. Cellular Tumor Antigen p53 Main Business and Markets Served
Table Aprea AB Cellular Tumor Antigen p53 Production Sites and Area Served
Table Aprea AB Cellular Tumor Antigen p53 Product Introduction, Application and Specification
Table Aprea AB Cellular Tumor Antigen p53 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Aprea AB Cellular Tumor Antigen p53 Production Growth Rate (2014-2019)
Table Aprea AB Cellular Tumor Antigen p53 Production Market Share (2014-2019)
Figure Aprea AB Cellular Tumor Antigen p53 Revenue Market Share (2014-2019)
Table Aprea AB Cellular Tumor Antigen p53 Main Business and Markets Served
Table Cellceutix Corporation Cellular Tumor Antigen p53 Production Sites and Area Served
Table Cellceutix Corporation Cellular Tumor Antigen p53 Product Introduction, Application and Specification
Table Cellceutix Corporation Cellular Tumor Antigen p53 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cellceutix Corporation Cellular Tumor Antigen p53 Production Growth Rate (2014-2019)
Table Cellceutix Corporation Cellular Tumor Antigen p53 Production Market Share (2014-2019)
Figure Cellceutix Corporation Cellular Tumor Antigen p53 Revenue Market Share (2014-2019)
Table Cellceutix Corporation Cellular Tumor Antigen p53 Main Business and Markets Served
Table Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Production Sites and Area Served
Table Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Product Introduction, Application and Specification
Table Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Production Growth Rate (2014-2019)
Table Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Production Market Share (2014-2019)
Figure Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Revenue Market Share (2014-2019)
Table Critical Outcome Technologies Inc. Cellular Tumor Antigen p53 Main Business and Markets Served
Table Eleos Inc. Cellular Tumor Antigen p53 Production Sites and Area Served
Table Eleos Inc. Cellular Tumor Antigen p53 Product Introduction, Application and Specification
Table Eleos Inc. Cellular Tumor Antigen p53 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eleos Inc. Cellular Tumor Antigen p53 Production Growth Rate (2014-2019)
Table Eleos Inc. Cellular Tumor Antigen p53 Production Market Share (2014-2019)
Figure Eleos Inc. Cellular Tumor Antigen p53 Revenue Market Share (2014-2019)
Table Eleos Inc. Cellular Tumor Antigen p53 Main Business and Markets Served
Table ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Production Sites and Area Served
Table ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Product Introduction, Application and Specification
Table ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Production Growth Rate (2014-2019)
Table ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Production Market Share (2014-2019)
Figure ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Revenue Market Share (2014-2019)
Table ORCA Therapeutics B.V. Cellular Tumor Antigen p53 Main Business and Markets Served
Table OSE Pharma SA Cellular Tumor Antigen p53 Production Sites and Area Served
Table OSE Pharma SA Cellular Tumor Antigen p53 Product Introduction, Application and Specification
Table OSE Pharma SA Cellular Tumor Antigen p53 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table OSE Pharma SA Cellular Tumor Antigen p53 Production Growth Rate (2014-2019)
Table OSE Pharma SA Cellular Tumor Antigen p53 Production Market Share (2014-2019)
Figure OSE Pharma SA Cellular Tumor Antigen p53 Revenue Market Share (2014-2019)
Table OSE Pharma SA Cellular Tumor Antigen p53 Main Business and Markets Served
Table PCI Biotech Holding ASA Cellular Tumor Antigen p53 Production Sites and Area Served
Table PCI Biotech Holding ASA Cellular Tumor Antigen p53 Product Introduction, Application and Specification
Table PCI Biotech Holding ASA Cellular Tumor Antigen p53 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table PCI Biotech Holding ASA Cellular Tumor Antigen p53 Production Growth Rate (2014-2019)
Table PCI Biotech Holding ASA Cellular Tumor Antigen p53 Production Market Share (2014-2019)
Figure PCI Biotech Holding ASA Cellular Tumor Antigen p53 Revenue Market Share (2014-2019)
Table PCI Biotech Holding ASA Cellular Tumor Antigen p53 Main Business and Markets Served
Table Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Production Sites and Area Served
Table Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Product Introduction, Application and Specification
Table Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Production Growth Rate (2014-2019)
Table Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Production Market Share (2014-2019)
Figure Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Revenue Market Share (2014-2019)
Table Quark Pharmaceuticals, Inc. Cellular Tumor Antigen p53 Main Business and Markets Served
Table Stemline Therapeutics, Inc. Cellular Tumor Antigen p53 Production Sites and Area Served
Table Shenzen SiBiono GeneTech Co., Ltd. Cellular Tumor Antigen p53 Production Sites and Area Served
Table SK Biopharmaceuticals Co., Ltd. Cellular Tumor Antigen p53 Production Sites and Area Served
Table Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Production Sites and Area Served
Table Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Production Sites and Area Served
Figure Global Cellular Tumor Antigen p53 Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Cellular Tumor Antigen p53 Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Cellular Tumor Antigen p53 Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Cellular Tumor Antigen p53 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Cellular Tumor Antigen p53 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Cellular Tumor Antigen p53 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Cellular Tumor Antigen p53 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Cellular Tumor Antigen p53 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Cellular Tumor Antigen p53 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Cellular Tumor Antigen p53 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Cellular Tumor Antigen p53 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Cellular Tumor Antigen p53 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Cellular Tumor Antigen p53 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Cellular Tumor Antigen p53 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Cellular Tumor Antigen p53 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Cellular Tumor Antigen p53 by Type (2019-2025)
Table Global Consumption (K Pcs) of Cellular Tumor Antigen p53 by Application (2019-2025)
Table Cellular Tumor Antigen p53 Distributors List
Table Cellular Tumor Antigen p53 Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Advaxis, Inc.、American Gene Technologies International Inc.、Aprea AB、Cellceutix Corporation、Critical Outcome Technologies Inc.、Eleos Inc.、ORCA Therapeutics B.V.、OSE Pharma SA、PCI Biotech Holding ASA、Quark Pharmaceuticals, Inc.、Stemline Therapeutics, Inc.、Shenzen SiBiono GeneTech Co., Ltd.、SK Biopharmaceuticals Co., Ltd.、Tara Immuno-Oncology Therapeutics LLC、Z53 Therapeutics, LLC、

【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の細胞性腫瘍抗原p53市場(Global Cellular Tumor Antigen p53 Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 地域保健システムEHRの世界市場：規模・現状・予測
  • 世界のオレイン樹脂産業：成長傾向・競合分析
  • 世界の3-ヘキセニルサリチレート市場
  • 世界の塩化チオイルセル市場
  • 世界のシーダー市場
  • 世界の脂漏薬市場
  • 世界のポリアミドイミド樹脂市場
  • 世界の湿気硬化型接着剤市場
  • 世界の統合イーサネットコントローラー市場
  • 世界の機能性ファブリック市場
  • 世界のマレイン酸ジメチル市場
  • 世界のデジタルサイネージバータイプディスプレイ市場
  • 世界のビジネス用ヨット市場
  • 世界のビルトマウント太陽光発電（BMPV）市場
  • 世界の空気混合タンク市場